News | February 18, 2022
Bayer raises peak sales for Nubeqa to exceed €3 billion
Darolutamide is developed jointly by Bayer and Orion Corporation
Darolutamide is developed jointly by Bayer and Orion Corporation
On track to complete the BLA submission in the first half of 2022
Cysoni is a bionic device that paces the heart with real-time respiratory modulation. The innovation stems from the idea that heart rate increases and decreases with each breath in normal physiology, termed ‘respiratory sinus arrhythmia’ (RSA)
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
Ram’s appointment follows the launch of the CDI India division in October 2021.
The drug is priced at Rs 2000 for a course of 40 tablets
It is the generic version of molnupiravir
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
DCGI approved the drug based on the review of clinical data
Subscribe To Our Newsletter & Stay Updated
